Literature DB >> 32934065

The national Targeted Lung Health Checks programme: Focusing on the lungs does not mean missing adrenal lesions.

Imran Hussain1, Anthony A Fryer2, Janina Barnett1, Fahmy Wf Hanna3.   

Abstract

Recently, the UK's national Targeted Lung Health Checks programme produced recommendations for the management of incidental findings identified during the scans performed as part of the lung cancer screening programme. We identified significant discrepancies between the recommendations for adrenal incidentaloma management and those currently implemented into UK practice (2016 European Society of Endocrinology guidelines).This may create conflict and confusion between referrers (respiratory clinicians) and receivers (endocrinologists), with potential negative impact on patients, delay and inefficient use of resources. We also address the potential cost implications of adopting a more vigilant approach as advised by the European Society of Endocrinology.Urgent multidisciplinary and unified guidelines should be established in the interest of clinical- and cost-effectiveness. © Royal College of Physicians 2020. All rights reserved.

Entities:  

Keywords:  Adrenal; incidentaloma; lung cancer; screening

Mesh:

Year:  2020        PMID: 32934065      PMCID: PMC7539722          DOI: 10.7861/clinmed.2020-0231

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  6 in total

Review 1.  The clinically inapparent adrenal mass: update in diagnosis and management.

Authors:  Georg Mansmann; Joseph Lau; Ethan Balk; Michael Rothberg; Yukitaka Miyachi; Stefan R Bornstein
Journal:  Endocr Rev       Date:  2004-04       Impact factor: 19.871

2.  The value of CT scanning and percutaneous fine needle aspiration of adrenal masses in biopsy-proven lung cancer.

Authors:  A Gillams; C M Roberts; P Shaw; S G Spiro; P Goldstraw
Journal:  Clin Radiol       Date:  1992-07       Impact factor: 2.350

3.  Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study.

Authors:  Guido Di Dalmazi; Valentina Vicennati; Silvia Garelli; Elena Casadio; Eleonora Rinaldi; Emanuela Giampalma; Cristina Mosconi; Rita Golfieri; Alexandro Paccapelo; Uberto Pagotto; Renato Pasquali
Journal:  Lancet Diabetes Endocrinol       Date:  2014-01-29       Impact factor: 32.069

4.  Adrenal Incidentalomas are Tied to Increased Risk of Diabetes: Findings from a Prospective Study.

Authors:  Giuseppe Reimondo; Elena Castellano; Maurizio Grosso; Roberto Priotto; Soraya Puglisi; Anna Pia; Micaela Pellegrino; Giorgio Borretta; Massimo Terzolo
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

5.  Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.

Authors:  Martin Fassnacht; Wiebke Arlt; Irina Bancos; Henning Dralle; John Newell-Price; Anju Sahdev; Antoine Tabarin; Massimo Terzolo; Stylianos Tsagarakis; Olaf M Dekkers
Journal:  Eur J Endocrinol       Date:  2016-08       Impact factor: 6.664

6.  Adrenal lesions found incidentally: how to improve clinical and cost-effectiveness.

Authors:  Fahmy W F Hanna; Basil G Issa; Simon C Lea; Cherian George; Anurag Golash; Mike Firn; Seyi Ogunmekan; Elloise Maddock; Julius Sim; Georgios Xydopoulos; Richard Fordham; Anthony A Fryer
Journal:  BMJ Open Qual       Date:  2020-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.